Comparative study of selegiline plus L-dopa-carbidopa versus L-dopa-carbidopa alone in the treatment of Parkinson's diseaseBRANNAN, T; YAHR, M. D.Annals of neurology. 1995, Vol 37, Num 1, pp 95-98, issn 0364-5134Article

Focal tremor following striatal infarct: A case reportBRANNAN, T; YAHR, M. D.Movement disorders. 1999, Vol 14, Num 2, pp 368-370, issn 0885-3185Article

Catechol-O-methyltransferase inhibition increases striatal L-dopa and dopamine : an in vivo study in ratsBRANNAN, T; MARTINEZ-TICA, J; YAHR, M. D et al.Neurology. 1992, Vol 42, Num 3, pp 683-685, issn 0028-3878, 1Article

Direct evidence of acute, massive striatal dopamine release in gerbils with unilateral strokesBRANNAN, T; WEINBERGER, J; KNOTT, P et al.Stroke (1970). 1987, Vol 18, Num 1, pp 108-110, issn 0039-2499Article

Variable onset of adult inherited focal dystonia: a problem for genetic studiesMICHELI, S; FERNANDEZ-PARDAL, M; QUESADA, P et al.Movement disorders. 1994, Vol 9, Num 1, pp 64-68, issn 0885-3185Article

L-threodops increases extracellular norepinephrine levels in the brain : an in vivo studyBRANNAN, T; BHARDWAJ, A; YAHR, M. D et al.Neurology. 1990, Vol 40, Num 7, pp 1134-1135, issn 0028-3878, 2 p.Article

Amine-mediated toxicity: the effects of dopamine, norepinephrine, 5-hydroxytryptamine, 6-hydroxydopamine, ascorbate, glutathione and peroxide on the in vitro activities of creatine and adenylate kinases in the brain of the ratMAKER, H. S; WEISS, C; BRANNAN, T. S et al.Neuropharmacology. 1986, Vol 25, Num 1, pp 25-32, issn 0028-3908Article

An in vivo comparison of the capacity of striatal versus extrastriatal brain regions to form dopamine from exogenously administered L-dopaBRANNAN, T; PRIKHOJAN, A; YAHR, M. D et al.Journal of neural transmission. 1996, Vol 103, Num 11, pp 1287-1294, issn 0300-9564Article

Effect of a selective MAO-A inhibitor (Ro 41-1049) on striatal L-dopa and dopamine metabolism: an in vivo studyBRANNAN, T; PRIKHOJAN, A; YAHR, M. D et al.Journal of neural transmission - Parkinson's disease and dementia section. 1994, Vol 8, Num 1-2, pp 99-105, issn 0936-3076Article

Effect of dietary protein on striatal dopamine formation following L-dopa administration : an In vivo studyBRANNAN, T; MARTINEZ-TICA, J; YAHR, M. D et al.Neuropharmacology. 1991, Vol 30, Num 10, pp 1125-1127, issn 0028-3908Article

Effect of yohimbine on brain monoamines : an in vivo studyBRANNAN, T; MARTINEZ-TICA, J; YAHR, M. D et al.Journal of neural transmission - Parkinson's disease and dementia section. 1991, Vol 3, Num 2, pp 81-87, issn 0936-3076Article

The effects of BCNU(1,3-bis(2-chloroethyl)-1-nitrosourea) and CCNU(1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea) on glutathione reductase and other enzymes in mouse tissue = Les effets du BCNU (1,3-bis(2-chloroéthyl)-1-nitrosourée) et du CCNU(1-(2-chloroéthyl)-3-cyclohexyl-1-nitrosourée) sur la glutathion réductase et d'autres enzymes dans le tissu de sourisMAKER, H. S; WEISS, C; BRANNAN, T. S et al.Research communications in chemical pathology and pharmacology. 1983, Vol 40, Num 3, pp 355-366, issn 0034-5164Article

Intrastriatal iron perfusion releases dopamine: an in-vivo microdialysis studyPRIKHOJAN, A; BRANNAN, T; YAHR, M. D et al.Journal of neural transmission. 2002, Vol 109, Num 5-6, pp 645-649, issn 0300-9564Article

Comparative effects of repeated administration of dopamine agonists on circling behavior in ratsPRIKHOJAN, A; BRANNAN, T; YAHR, M. D et al.Journal of neural transmission. 2000, Vol 107, Num 10, pp 1159-1164, issn 0300-9564Article

Elevated striatal dopamine levels following administration of D-DOPA and its α-keto acid metabolite DHPPA : behavioral and physiological studies in vivo in the ratBRANNAN, T; PRIKHOJAN, A; YAHR, M. D et al.Brain research. 1996, Vol 718, Num 1-2, pp 165-168, issn 0006-8993Article

Pentobarbital inhibits extracellular release of dopamimne in the ischemic striatumBHARDWAJ, A; BRANNAN, T; WEINBERGER, J et al.Journal of neural transmission. 1990, Vol 85, Num 4, pp 111-117, issn 0300-9564, 7 p.Article

Nitric oxide modulates dopamine release during global temporary cerebral ischemiaKAHN, R. A; WEINBERGER, J; BRANNAN, T et al.Anesthesia and analgesia. 1995, Vol 80, Num 6, pp 1116-1121, issn 0003-2999Article

Dystonic storms : a practical management problemVAAMONDE, J; NARBONA, J; WEISER, R et al.Clinical neuropharmacology. 1994, Vol 17, Num 4, pp 344-347, issn 0362-5664Article

Ischemia in the dorsal hippocampus is associated with acute extracellular release of dopamine and norepinephrineBHARDWAJ, A; BRANNAN, T; MARTINEZ-TICA, J et al.Journal of neural transmission. 1990, Vol 80, Num 3, pp 195-201, issn 0300-9564Article

In vivo comparison of the effects of inhibition of MAO-A versus MAO-B on striatal L-DOPA and dopamine metabolismBRANNAN, T; PRIKHOJAN, A; MARTINEZ-TICA, J et al.Journal of neural transmission - Parkinson's disease and dementia section. 1995, Vol 10, Num 2-3, pp 79-89, issn 0936-3076Article

Low and high dose bromocriptine have different effects on striatal dopamine release: an vivo studyBRANNAN, T; MARTINEZ-TICA; DI ROCCO, A et al.Journal of neural transmission - Parkinson's disease and dementia section. 1993, Vol 6, Num 2, pp 81-87, issn 0936-3076Article

Intracerebral dialysis monitoring of striatal dopamine release and metabolism in response to L-DOPABRANNAN, T; KNOTT, P; KAUFMANN, H et al.Journal of neural transmission. 1989, Vol 75, Num 2, pp 149-157, issn 0300-9564Article

Effect of etomidate on in vitro ischemia-induced dopamine release in the corpus striatum of the rat : a study using cerebral microdialysisKOORN, R; BRANNAN, T. S; MARTINEZ-TICA, J et al.Anesthesia and analgesia. 1994, Vol 78, Num 1, pp 73-79, issn 0003-2999Article

Increase in extracellular dopamine in the striatum during cerebral ischemia: a study utilizing cerebral microdialysisSLIVKA, A; BRANNAN, T. S; WEINBERGER, J et al.Journal of neurochemistry. 1988, Vol 50, Num 6, pp 1714-1718, issn 0022-3042Article